Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
5.16
+0.12 (2.38%)
At close: May 15, 2026, 4:00 PM EDT
4.200
-0.960 (-18.60%)
After-hours: May 15, 2026, 7:02 PM EDT
LIXT Market Cap
LIXT has a market cap or net worth of $59.95 million as of May 15, 2026. Its market cap has increased by 1,663.19% in one year.
Market Cap
59.95M
Enterprise Value
57.76M
1-Year Change
1,663.19%
Ranking
Category
Stock Price
$5.16
Market Cap Chart
Since November 25, 2020, LIXT's market cap has increased from $47.40M to $59.95M, an increase of 26.47%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 63.90M | 185.27% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 62.58M |
| BeyondSpring | 60.45M |
| Immutep | 59.94M |
| Filana Therapeutics | 59.90M |
| Impact BioMedical | 59.30M |
| KALA BIO | 57.44M |
| iBio, Inc. | 56.38M |
| aTyr Pharma | 54.90M |